The effect of neoadjuvant chemotherapy on estrogen and progesterone receptor expression in breast carcinoma / 中华外科杂志
Chinese Journal of Surgery
;
(12): 1011-1013, 2005.
Article
in Chinese
| WPRIM
| ID: wpr-306146
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the effect of neoadjuvant chemotherapy on estrogen receptor (ER) and progesterone receptor (PR) expression in breast carcinoma.</p><p><b>METHODS</b>Samples were obtained from 31 patients with breast carcinoma who received neo-adjuvant chemotherapy, ER or PR expressions were analyzed in preoperative core biopsies and final surgical specimens.</p><p><b>RESULTS</b>ER level was up-regulated in 13 (41.9%) out of 31 cases, PR level was up-regulated in 10 (32.3%). Both ER level and PR level were up-regulated in 8 (25.8%) out of 31 cases.</p><p><b>CONCLUSIONS</b>Neoadjuvant chemotherapy may impact the hormone receptor status, ER and PR expression re-analysis in final surgical specimens is recommended.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Breast Neoplasms
/
Immunohistochemistry
/
Epirubicin
/
Antineoplastic Combined Chemotherapy Protocols
/
Receptors, Progesterone
/
Receptors, Estrogen
/
Follow-Up Studies
/
Chemotherapy, Adjuvant
/
Paclitaxel
/
Neoadjuvant Therapy
Type of study:
Observational study
/
Prognostic study
Limits:
Female
/
Humans
Language:
Chinese
Journal:
Chinese Journal of Surgery
Year:
2005
Type:
Article
Similar
MEDLINE
...
LILACS
LIS